IP Library Granted Patent US 9,540,515
Granted Patent B2
US 9,540,515 · App. 13/736,999 · Granted Jan 10, 2017

Fluorescence quenching azo dyes, their methods of preparation and use

Inventors: Andrei Laikhter (Lexington, MA); Mark Aaron Behlke (Coralville, IA); Joseph Walder (Chicago, IL); Kevin William Roberts (Iowa City, IA); Yawfui Yong (Coralville, IA)
Assignee: Integrated DNA Technologies, Inc.
C09B29/00C07C245/10C07F9/091C07F9/2408C07H21/04Y10T436/143333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,540,515
App. No.
13/736,999
Granted
Jan 10, 2017
Kind
B2
Abstract

Disclosed is a group of azo quencher compositions useful as fluorescence quenchers having the general structure of formula 1, methods of making or using the compositions, and kits comprising the composition.

Claims (14)

1. A method for making an oligonucleotide, comprising introducing the compound of Formula 1 to an automated oligonucleotide synthesizer to chemically incorporate a quencher compound into the oligonucleotide:

wherein R 1-6 on the conjugated ring system are individually an electron withdrawing group, alkyl group, aryl group, hydrogen, heteroaryl group, or a five or six member ring structure formed from the R 1 , R 2 pair, the R 3 , R 4 pair, the R 4 , R 5 pair, or the R 5 , R 6 pair; and wherein R 7 is an anilyl group of Formula 2:

wherein L and L′ are the same or different and are a C 1-10 group, —C 1-10 —O—R 8 , or —C 1-10 —O—R 9 , wherein C 1-10 is a C 1-10 alkyl group, and R 8 and R 9 are independently a hydrogen, trityl, alkoxytrityl, silyl, or phosphoramidite with the proviso that when L or L′ is ethyl, then the other is not hydroxyethyl, and

wherein at least one of L or L′ is —C 1-10 —O—R 8 or —C 1-10 —O—R 9 , and at least one of R 8 and R 9 is a phosphoramidite.

2. The method of claim 1 , wherein the phosphoramidite group is a cyanoethylphosphoramidite.

3. The method of claim 2 , wherein the quencher compound is coupled to the 3′-terminus of the oligonucleotide.

4. The method of claim 3 , wherein the quencher compound is coupled to the 5′-terminus of the oligonucleotide.

5. The method of claim 1 , wherein the synthesis step comprises linking the compound of Formula 1 to a solid support.

6. The method of claim 5 , wherein the solid support is controlled pore glass.

7. The method of claim 1 , wherein the compound of Formula 1 is the compound of Formula 13:

wherein CEP is cyanoethylphosphoramidite.

8. The method of claim 1 , wherein the compound of Formula 1 is the compound of Formula 14:

wherein CEP is cyanoethylphosphoramidite.

9. The method of claim 1 , wherein the oligonucleotide further comprises a fluorophore.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2017
From: JPMORGAN CHASE BANK, N.A.
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 044167/0215 →
SECURITY INTEREST Recorded Feb 1, 2016
From: INTEGRATED DNA TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 037675/0041 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2013
From: LAIKHTER, ANDREI; BEHLKE, MARK AARON; WALDER, JOSEPH; ROBERTS, KEVIN WILLIAM; YONG, YAWFUI
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 030505/0988 →
Continuity (5)
Continuation 13298479 · Nov 17, 2011
Division 12252721 · Oct 16, 2008
Division 10987608 · Nov 12, 2004
Provisional Application 60520077 · Nov 14, 2003
Related Publication 20130116415A1 · May 9, 2013